Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-13-000812
Filing Date
2013-07-16
Accepted
2013-07-16 19:56:51
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2914
  Complete submission text file 0000904454-13-000812.txt   4409
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

EIN.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address
Kamdar Kim P. (Reporting) CIK: 0001535065 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35119 | Film No.: 13971340